Asthma exacerbation is induced by the interaction of genes and environmental factors such as cigarette smoke. NLRP4 counteracts the activity of the inflammasome, which is responsible for asthma exacerbation. In this study, we analyzed the association of single-nucleotide polymorphisms of NLRP4 with the annual rate of exacerbation and evaluated the additive effect of smoking in 1454 asthmatics. Asthmatics possessing the minor allele of rs1696718G > A had more frequent exacerbation episodes than those homozygous for the common allele (0.59 vs. 0.36/year) and the association was present only in current and ex-smokers. There was a significant interaction between the amount smoked and rs16986718 genotypes (p = 0.014) and a positive correlation between the number of annual exacerbation episodes and amount smoked only in rs16986718G > A AA homozygotes. The prevalence of frequent exacerbators (≥2 exacerbation episodes/year) was 2.5 times higher in rs16986718G > A minor allele homozygotes than in common allele homozygotes (12.0% vs. 5.9%). Furthermore, the prevalence was 6 times higher in rs16986718G > A minor allele homozygotes who were current and ex-smokers than in nonsmokers (25.6% vs. 4.1%). The minor allele of rs16986718G > A in NLRP4 may be a genetic marker that predicts asthma exacerbation in adult asthmatics who smoke.
Get full access to this article
View all access options for this article.
References
1.
BauerR.N., Diaz-SanchezD., and JaspersI. (2012). Effects of air pollutants on innate immunity: the role of Toll-like receptors and nucleotide-binding oligomerization domain-like receptors. J Allergy Clin Immunol, 129, 14–24; quiz 5–6.
2.
BisgaardH., BonnelykkeK., SleimanP.M., BrasholtM., ChawesB., Kreiner-MollerE., et al. (2009). Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood. Am J Respir Crit Care Med, 179, 179–185.
3.
BloombergG.R. (2011). The influence of environment, as represented by diet and air pollution, upon incidence and prevalence of wheezing illnesses in young children. Curr Opin Allergy Clin Immunol, 11, 144–149.
4.
BonnelykkeK., SleimanP., NielsenK., Kreiner-MollerE., MercaderJ.M., BelgraveD., et al. (2014). A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet, 46, 51–55.
5.
BukvicB.K., BlekicM., SimpsonA., MarinhoS., CurtinJ.A., HankinsonJ., et al. (2013). Asthma severity, polymorphisms in 20p13 and their interaction with tobacco smoke exposure. Pediatr Allergy Immunol, 24, 10–18.
6.
BusackerA., NewellJ.D.Jr., KeefeT., HoffmanE.A., GranrothJ.C., CastroM., et al. (2009). A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. Chest, 135, 48–56.
7.
ChanezP., WenzelS.E., AndersonG.P., AntoJ.M., BelE.H., BouletL.P., et al. (2007). Severe asthma in adults: what are the important questions?. J Allergy Clin Immunol, 119, 1337–1348.
8.
CuiJ., LiY., ZhuL., LiuD., SongyangZ., WangH.Y., et al. (2012). NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat Immunol, 13, 387–395.
9.
CunninghamJ., BasuK., TavendaleR., PalmerC.N., SmithH., and MukhopadhyayS. (2011). The CHI3L1 rs4950928 polymorphism is associated with asthma-related hospital admissions in children and young adults. Ann Allergy Asthma Immunol, 106, 381–386.
10.
DahlinA., DennyJ., RodenD.M., BrilliantM.H., IngramC., KitchnerT.E., et al. (2015). CMTR1 is associated with increased asthma exacerbations in patients taking inhaled corticosteroids. Immun Inflamm Dis, 3, 350–359.
11.
De NardoD., De NardoC.M., and LatzE. (2014). New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease. Am J Pathol, 184, 42–54.
12.
DenlingerL.C., MantheiD.M., SeiboldM.A., AhnK., BleeckerE., BousheyH.A., et al. (2013). P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy. Am J Respir Crit Care Med, 187, 28–33.
13.
DinarelloC.A. (2009). Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol, 27, 519–550.
14.
DoughertyR.H., and FahyJ.V. (2009). Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy, 39, 193–202.
15.
FiorentinoL., StehlikC., OliveiraV., ArizaM.E., GodzikA., and ReedJ.C. (2002). A novel PAAD-containing protein that modulates NF-kappa B induction by cytokines tumor necrosis factor-alpha and interleukin-1beta. J Biol Chem, 277, 35333–35340.
16.
HuangFuW.C., LiuJ., HartyR.N., and FuchsS.Y. (2008). Cigarette smoking products suppress anti-viral effects of Type I interferon via phosphorylation-dependent downregulation of its receptor. FEBS Lett, 582, 3206–3210.
17.
HunninghakeG.M., Soto-QuirósM.E., AvilaL., SuJ., MurphyA., DemeoD.L., et al. (2007). Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood. J Allergy Clin Immunol, 120, 84–90.
18.
JiangD., LiangJ., LiY., and NobleP.W. (2006). The role of Toll-like receptors in non-infectious lung injury. Cell Res, 16, 693–701.
19.
KannegantiT.D. (2010). Central roles of NLRs and inflammasomes in viral infection. Nat Rev Immunol, 10, 688–698.
20.
KimC.K., CallawayZ., and GernJ.E. (2018). Viral infections and associated factors that promote acute exacerbations of asthma. Allergy Asthma Immunol Res, 10, 12–17.
21.
KimM.-A., ShinS.-W., ParkJ.-S., UhS.-T., ChangH.S., BaeD.-J., et al. (2017). Clinical characteristics of exacerbation-prone adult asthmatics identified by cluster analysis. Allergy Asthma Immunol Res 9,e35.
22.
Kimchi-SarfatyC., OhJ.M., KimI.W., SaunaZ.E., CalcagnoA.M., AmbudkarS.V., et al. (2007). A “silent”. polymorphism in the MDR1 gene changes substrate specificity. Science, 315, 525–528.
23.
Kljaic-BukvicB., BlekicM., AberleN., CurtinJ.A., HankinsonJ., Semic-JusufagicA., et al. (2014). Genetic variants in endotoxin signalling pathway, domestic endotoxin exposure and asthma exacerbations. Pediatr Allergy Immunol, 25, 552–557.
24.
KomarA.A. (2007). Silent SNPs: impact on gene function and phenotype. Pharmacogenomics, 8, 1075–1080.
25.
LanderE.S., LintonL.M., BirrenB., NusbaumC., ZodyM.C., BaldwinJ., et al. (2001). Initial sequencing and analysis of the human genome. Nature, 409, 860–921.
26.
LinM., ZhaoZ., YangZ., MengQ., TanP., XieW., et al. (2016). USP38 inhibits type I interferon signaling by editing TBK1 ubiquitination through NLRP4 signalosome. Mol Cell, 64, 267–281.
27.
McGeachieM.J., WuA.C., TseS.M., ClemmerG.L., SordilloJ., HimesB.E., et al. (2015). CTNNA3 and SEMA3D: promising loci for asthma exacerbation identified through multiple genome-wide association studies. J Allergy Clin Immunol, 136, 1503–1510.
28.
ModestouM.A., ManzelL.J., El-MahdyS., and LookD.C. (2010). Inhibition of IFN-gamma-dependent antiviral airway epithelial defense by cigarette smoke. Respir Res 11,64.
29.
MooreW.C., BleeckerE.R., Curran-EverettD., ErzurumS.C., AmeredesB.T., BacharierL., et al. (2007). Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol, 119, 405–413.
30.
NyholtD.R. (2004). A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet, 74, 765–769.
31.
ParkH.W., and TantisiraK.G. (2017). Genetic signatures of asthma exacerbation. Allergy Asthma Immunol Res, 9, 191–199.
32.
PolosaR., and ThomsonN.C. (2013). Smoking and asthma: dangerous liaisons. Eur Respir J, 41, 716–726.
33.
ReddelH.K., TaylorD.R., BatemanE.D., BouletL.P., BousheyH.A., BusseW.W., et al. (2009). An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med, 180, 59–99.
34.
SaxonA., and Diaz-SanchezD. (2005). Air pollution and allergy: you are what you breathe. Nat Immunol, 6, 223–226.
35.
SchroderK., and TschoppJ. (2010). The inflammasomes. Cell, 140, 821–832.
36.
SeoK.H., BaeD.J., KimJ.N., LeeH.S., KimY.H., ParkJ.S., et al. (2017). Prevalence of respiratory viral infections in Korean adult asthmatics with acute exacerbations: comparison with those with stable state. Allergy Asthma Immunol Res, 9, 491–498.
37.
StephensJ.C., SchneiderJ.A., TanguayD.A., ChoiJ., AcharyaT., StanleyS.E., et al. (2001). Haplotype variation and linkage disequilibrium in 313 human genes. Science, 293, 489–493.
38.
TurnerS., FrancisB., VijverbergS., Pino-YanesM., Maitland-van der ZeeA.H., BasuK., et al. (2016). Childhood asthma exacerbations and the Arg16 beta2-receptor polymorphism: a meta-analysis stratified by treatment. J Allergy Clin Immunol, 138, 107–113. e5.
39.
VenarskeD.L., BusseW.W., GriffinM.R., GebretsadikT., ShintaniA.K., MintonP.A., et al. (2006). The relationship of rhinovirus-associated asthma hospitalizations with inhaled corticosteroids and smoking. J Infect Dis, 193, 1536–1543.
WenzelS. (2005). Severe asthma in adults. Am J Respir Crit Care Med, 172, 149–160.
42.
WenzelS.E., BalzarS., AmplefordE., HawkinsG.A., BusseW.W., CalhounW.J., et al. (2007). IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression. Am J Respir Crit Care Med, 175, 570–576.
43.
WuA.C., Lasky-SuJ., RogersC.A., KlandermanB.J., and LitonjuaA.A. (2010). Fungal exposure modulates the effect of polymorphisms of chitinases on emergency department visits and hospitalizations. Am J Respir Crit Care Med, 182, 884–889.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
